New appointment to the Sebapharma Executive Board

Dr. Daniel Rothoeft named new Deputy Chairman of the Sebapharma Executive Board.

New management duo now in place, consisting of Chief Executive Officer Thomas Maurer together with Dr. Daniel Rothoeft.



Boppard, Germany, July 2020. Effective 1 July 2020, Dr. Daniel Rothoeft has been appointed the new Deputy Chairman of the Executive Board of Sebapharma GmbH & Co. KG, which offers medical skincare and cleansing products with a pH value of 5.5 under the sebamed brand. The 48-year-old has immediately assumed responsibility for the Global Marketing, IT, Finance, Logistics, Legal, HR and Administration departments. Dr. Daniel Rothoeft succeeds Dr. Rüdiger Mittendorff, who retired at the end of June after more than 26 years with the company.


Dr. Rothoeft, who holds a doctorate in economics, already worked for Sebapharma from 2006 to 2012, initially as personal assistant to the now deceased company founder Dr. Heinz Maurer and then in the role of Senior Head of Finance, Tax and Legal. Dr. Daniel Rothoeft rejoined the Boppard-based family company in July 2019. Before returning to Sebapharma, Dr. Rothoeft was most recently a member of the Extended Executive Board of the Berner Group, a construction supply firm. The keen ocean sailor is married and has one son.


“I will continue to pursue Sebapharma’s growth strategy and drive it with new ideas. The market for medical skin cleansing and care products is growing worldwide. I expect the sebamed brand consisting of products with a pH value of 5.5 to play a crucial and pioneering role here in the future. More and more people want products that have been medically and scientifically tested for cleansing, nourishing and also protecting their skin. With over 100 products, sebamed can help to preserve the skin’s natural protective mantle”, said Dr. Rothoeft, who is convinced that the sebamed brand will be even more popular among consumers going forward.